Baseline characteristics
MAY
Between May 2019 and April 2021, 6609 participants were randomized and
then followed for a median of 2·0 years. Prespecified subgroups of eGFR
included 2282 (35%), 2928 (44%) and 1399 (21%) with eGFR <30, ≥30
to <45 and ≥45 mL/min/1.73m